These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6404979)

  • 1. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
    Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM
    J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism.
    Prezelj J; Kocijancic A; Andolsek L
    Gynecol Endocrinol; 1989 Dec; 3(4):281-8. PubMed ID: 2516705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y
    Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of hirsutism in adolescent girls with spironolactone].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
    Sert M; Tetiker T; Kirim S
    Acta Med Okayama; 2003 Apr; 57(2):73-6. PubMed ID: 12866746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spironolactone in idiopathic hirsutism, clinical and biological evaluation of treatment].
    Abramovici Y; Guillet F; Matte R; Chaieb L; Belanger R
    Ann Endocrinol (Paris); 1983; 44(6):393-6. PubMed ID: 6430208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New alternative treatment in hirsutism: bicalutamide 25 mg/day.
    Müderris II; Bayram F; Ozçelik B; Güven M
    Gynecol Endocrinol; 2002 Feb; 16(1):63-6. PubMed ID: 11915584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of spironolactone on hirsutism and female androgen metabolism.
    Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic strategy in hyperandrogenic syndrome.
    Rüedi B; Margalith D; Magrini G; Burckhardt P
    Horm Res; 1983; 18(1-3):117-24. PubMed ID: 6224729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
    Vĕtr M; Sobek A
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
    Suraci C; Costa C; De Pedrini P
    Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.